Improved health when treatment for both hepatitis C and opioid use disorder are offered

Amenorrhea linked to bone loss in HIV-positive women

Traditional risk factors have a big impact on bone thinning in HIV-positive people

Managing medicines may become more difficult as some HIV-positive people age

More

Can't Pass It On
Learn more

Webinar – Indigenous-centred approaches to harm reduction, HIV and hepatitis C: Part 2

March 3, 2020
12:00 p.m. EST

Webinar – Lessons learned from an injectable opioid agonist therapy (iOAT) program in British Columbia

March 10, 2020
12:00 p.m. EDT

Webinar – Linking testing to treatment: Update on hepatitis C care in Ontario

March 16, 2020
12:00 p.m. EDT

More

9th Canadian Symposium on Hepatitis C Virus

Canadian Network on Hepatitis C (CanHepC)
February 28, 2020
Montreal, QC

Canadian Liver Meeting

Canadian Association for the Study of the Liver (CASL), Canadian Network on Hepatitis C (CanHepC) and the Canadian Association of Hepatology Nurses (CAHN)
February 28 to March 1, 2020
Montreal, QC

RHO 2020

Rainbow Health Ontario
April 21 to 23, 2020
Niagara Falls, ON

More

Indigenous-centered approaches to harm reduction and hepatitis C programs (CATIE)

Harm Reduction Satellite Sites Program (CATIE Programming Connection case study)

TreatmentUpdate 235 (CATIE)

The Maple Leaf PrEP Clinic (CATIE Programming Connection case study)

Testimonials of people living with HIV (PHAC video)

More